According to RadNet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.21858. At the end of 2023 the company had a P/S ratio of 1.46.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.46 | 93.34% |
2022 | 0.7553 | -38.27% |
2021 | 1.22 | 29.76% |
2020 | 0.9429 | 6.55% |
2019 | 0.8849 | 73.25% |
2018 | 0.5108 | -2.07% |
2017 | 0.5216 | 53.93% |
2016 | 0.3388 | -4.09% |
2015 | 0.3533 | -30.69% |
2014 | 0.5097 | 435.18% |
2013 | 0.0952 | -36.79% |
2012 | 0.1507 | 12.81% |
2011 | 0.1336 | -30.21% |
2010 | 0.1914 | 35.66% |
2009 | 0.1411 | -39.27% |
2008 | 0.2323 | -72.68% |
2007 | 0.8502 | 21.23% |
2006 | 0.7013 | 566.38% |
2005 | 0.1052 | -37.24% |
2004 | 0.1677 | 15.63% |
2003 | 0.1450 | -38.57% |
2002 | 0.2361 | -31.56% |
2001 | 0.3449 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | 1.59 | -28.21% | ๐บ๐ธ USA |
LabCorp LH | 1.42 | -35.81% | ๐บ๐ธ USA |
Psychemedics PMD | 0.7633 | -65.60% | ๐บ๐ธ USA |
Enzo Biochem ENZ | 5.08 | 128.98% | ๐บ๐ธ USA |